BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 4, 2015
View Archived Issues
Athersys and Chugai sign Japanese agreement for MultiStem in ischemic stroke
Read More
FDA approves Liletta to prevent pregnancy for up to three years
Read More
GSK/Novartis transaction complete
Read More
Cardinal Health offers to acquire Cordis from Johnson & Johnson
Read More
FDA grants breakthrough therapy designation to Epstein-Barr virus targeted T cells
Read More
SBIR supports collaborative work in brain cancer between Nascent Biotech and Mapp Biopharmaceutical
Read More
Multiplatform tumor profiling shows potential for therapeutic decision-making
Read More
Dilafor releases results from safety and pharmacokinetic study of tafoxiparin
Read More
Anticoagulant-reversing agent andexanet alfa given FDA orphan drug status
Read More
Alkermes highlights new drug candidate, ALKS-7119
Read More
Alize Pharma begins phase II trial of AZP-531 in Prader-Willi syndrome
Read More
Lupin patents CaSR modulators
Read More
Constellation Pharmaceuticals reports development of EZH2 inhibitors
Read More
British investigators prepare new oligomers for muscular dystrophy
Read More
Resilience and PsychoGenics form drug discovery partnership
Read More
Celimmune enters into licensing and option agreement with Amgen to develop AMG-714
Read More
Mast Therapeutics reports data from nonclinical study of vepoloxamer in advanced heart failure
Read More
Clearside Biomedical begins phase II trial of CLS-TA in macular edema
Read More
FIOCRUZ patents new compounds for respiratory inflammatory diseases
Read More
Merck KGaA reports new tankyrase inhibitors
Read More
Denovo Biopharma licenses Lilly's pomaglumetad methionil
Read More
Pulmokine secures funding for phase I trial of PDGF receptor kinase inhibitor PK-10571
Read More
Prevenar 13 approved in E.U. for prevention of pneumococcal pneumonia in adults
Read More
Novel means of blocking Ebola entry into cells with existing agents identified
Read More
PSMA antibody-drug conjugate shows potential for the treatment of prostate cancer
Read More